WMT

117.8

-1.32%↓

COST

975.29

-0.73%↓

TGT

106.54

+0.43%↑

KR

62.61

-1.9%↓

DG.US

144.52

-1.72%↓

WMT

117.8

-1.32%↓

COST

975.29

-0.73%↓

TGT

106.54

+0.43%↑

KR

62.61

-1.9%↓

DG.US

144.52

-1.72%↓

WMT

117.8

-1.32%↓

COST

975.29

-0.73%↓

TGT

106.54

+0.43%↑

KR

62.61

-1.9%↓

DG.US

144.52

-1.72%↓

WMT

117.8

-1.32%↓

COST

975.29

-0.73%↓

TGT

106.54

+0.43%↑

KR

62.61

-1.9%↓

DG.US

144.52

-1.72%↓

WMT

117.8

-1.32%↓

COST

975.29

-0.73%↓

TGT

106.54

+0.43%↑

KR

62.61

-1.9%↓

DG.US

144.52

-1.72%↓

Search

USANA Health Sciences Inc

Geschlossen

22.41 1.63

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

21.98

Max

22.79

Schlüsselkennzahlen

By Trading Economics

Einkommen

-17M

-6.7M

Verkäufe

-22M

214M

KGV

Branchendurchschnitt

24.367

29.272

EPS

-0.15

Gewinnspanne

-3.118

Angestellte

1,700

EBITDA

-17M

11M

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+75.36% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

24. Feb. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

19M

401M

Vorheriger Eröffnungskurs

20.78

Vorheriger Schlusskurs

22.41

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

USANA Health Sciences Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

22. Jan. 2026, 21:55 UTC

Ergebnisse

Capital One Financial Posts Higher 4Q Profit As Lending Increases

22. Jan. 2026, 23:52 UTC

Ergebnisse

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- Update

22. Jan. 2026, 23:48 UTC

Market Talk

Nikkei May Rise as Tensions Between U.S. and Europe Ease -- Market Talk

22. Jan. 2026, 23:42 UTC

Market Talk

Gold Edges Lower on Possible Profit-Taking -- Market Talk

22. Jan. 2026, 23:40 UTC

Market Talk

Spark NZ's Market Share Loss Concerns Bear -- Market Talk

22. Jan. 2026, 23:30 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

22. Jan. 2026, 23:30 UTC

Market Talk

Genesis Energy Can Beat Newly Upgraded Earnings Goal -- Market Talk

22. Jan. 2026, 22:37 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Capital One CEO: Brex Buy Reflects Business Payments Focus -- Market Talk

22. Jan. 2026, 21:59 UTC

Akquisitionen, Fusionen, Übernahmen

Capital One Strikes $5.15 Billion Deal for Fintech Brex -- Update

22. Jan. 2026, 21:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Tech, Media & Telecom Roundup: Market Talk

22. Jan. 2026, 21:44 UTC

Ergebnisse

Self-Driving Stock Mobileye Plunged After Earnings. Here's Why. -- Barrons.com

22. Jan. 2026, 21:32 UTC

Akquisitionen, Fusionen, Übernahmen

Capital One: Brex Invented Integrated Combination of Corporate Credit Cards, Spend Management Software and Banking in Single Platform >COF

22. Jan. 2026, 21:31 UTC

Akquisitionen, Fusionen, Übernahmen

Capital One: Brex Is a Modern, AI-native Software Platform Offering Intelligent Finance Solutions >COF

22. Jan. 2026, 21:31 UTC

Akquisitionen, Fusionen, Übernahmen

Capital One: Franceschi Will Continue to Lead Brex as Part of Capital One >COF

22. Jan. 2026, 21:30 UTC

Akquisitionen, Fusionen, Übernahmen

Capital One to Acquire Brex in Combination of Stk and Cash Transaction Valued at $5.15 B >COF

22. Jan. 2026, 21:30 UTC

Ergebnisse

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results -- WSJ

22. Jan. 2026, 21:30 UTC

Akquisitionen, Fusionen, Übernahmen

Capital One To Acquire Brex >COF

22. Jan. 2026, 21:13 UTC

Ergebnisse

Intel Returns to Losses in Q4 as It Ramps Up Spending on Chip Production -- WSJ

22. Jan. 2026, 21:11 UTC

Ergebnisse

Intuitive Surgical Sees 2026 Impact From Tariffs 1.2% of Revenue, Plus or Minus 10 Basis Points >ISRG

22. Jan. 2026, 21:11 UTC

Ergebnisse

Intuitive Surgical Sees 2026 Adjusted Gross Profit Margin 67%-68% >ISRG

22. Jan. 2026, 21:10 UTC

Ergebnisse

Intuitive Surgical Sees 2026 Worldwide Da Vinci Procedure Growth of 13%-15% >ISRG

22. Jan. 2026, 21:06 UTC

Ergebnisse

Capital One 4Q Total Non-Interest Expense Increased 13% to $9.3B >COF

22. Jan. 2026, 21:05 UTC

Ergebnisse

Capital One 4Q Provision for Credit Losses Increased $4.1B >COF

22. Jan. 2026, 21:05 UTC

Ergebnisse

Capital One 4Q Rev $15.58B >COF

22. Jan. 2026, 21:05 UTC

Ergebnisse

Capital One 4Q EPS $3.26 >COF

22. Jan. 2026, 21:05 UTC

Ergebnisse

Capital One 4Q Net Interest Margin 8.26% >COF

22. Jan. 2026, 21:05 UTC

Ergebnisse

Capital One 4Q Net $2.13B >COF

22. Jan. 2026, 21:05 UTC

Ergebnisse

Capital One 4Q Adj EPS $3.86 >COF

22. Jan. 2026, 21:05 UTC

Ergebnisse

Capital One 4Q Net Charge-Offs $3.8B >COF

22. Jan. 2026, 21:05 UTC

Ergebnisse

Intuitive Surgical 4Q EPS $2.21 >ISRG

Peer-Vergleich

Kursveränderung

USANA Health Sciences Inc Prognose

Kursziel

By TipRanks

75.36% Vorteil

12-Monats-Prognose

Durchschnitt 39 USD  75.36%

Hoch 39 USD

Tief 39 USD

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für USANA Health Sciences Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

1 ratings

0

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

28.405 / 29.84Unterstützung & Widerstand

Kurzfristig

Weak Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

No Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
help-icon Live chat